Kanazawa University · Graduate School of Medical, Pharmaceutical and Health Sciences · 特任助教

Research keywords肺癌・薬剤耐性・Man・With・Progressive・Dyspnea・Diffuse・Lung

Research fieldsRespiratory organ internal medicine

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• MET Enhances Amivantamab Binding to EGFR and Antibody-Dependent Cellular Toxicity.
• Unexpected Diffuse Alveolar Hemorrhage After Bronchoscopy.
• A 72-Year-Old Man With Progressive Dyspnea and Diffuse Lung Disease.
• Five-year efficacy and safety of pembrolizumab as first-line treatment in patients with non-small cell lung cancer with PD-L1 tumor proportion score ≥50 %: A multicenter observational study.

• Official profile